Status:
WITHDRAWN
Improving Patient Outcomes Through the Implementation of an IBD Biologic Care Pathway
Lead Sponsor:
Jennifer Jones
Collaborating Sponsors:
Nova Scotia Health Authority
Conditions:
Inflammatory Bowel Diseases
Ulcerative Colitis
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Inflammatory Bowel Disease (IBD) includes a group of chronic inflammatory conditions of the gastrointestinal system and is composed of Crohn's disease and ulcerative colitis. As an immune-mediated dis...
Eligibility Criteria
Inclusion
- Greater than or equal to age 18
- Starting an Anti TNF biologic therapy or Biosimilar
Exclusion
- High-grade, symptomatic fibrostenotic strictures
- Perforating complications
- Intraabdominal or perianal abscesses
- Active infection,
- Known malignancy
- Any contraindication to biologic therapy
Key Trial Info
Start Date :
March 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06030882
Start Date
March 25 2024
End Date
July 1 2025
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 2Y9